| Literature DB >> 35296787 |
Chih-Wei Sung1, Kao-Lang Liu2, Hsiu-Po Wang3, I-Chung Chen4, Edward Pei-Chuan Huang1,5, Wan-Ching Lien6, Chien-Hua Huang5.
Abstract
Evidence regarding the recurrence of diverticulitis is limited in Asian patients. This study aims to investigate recurrence rates and identify predictive factors for the recurrence of diverticulitis following successful nonoperative treatment in Asian patients. A multicenter, retrospective cohort study was conducted between 2012 and 2018. Adult patients with computed tomography (CT)-proven colonic diverticulitis were included. The primary outcome was the recurrence of diverticulitis, which was defined as another episode of occurrence of the infection after index hospital stay. Cumulative recurrence rates were calculated using the Kaplan-Meier method. Cox regression models were employed to identify parameters that significantly and independently predicted recurrence. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated. A total of 929 patients were included. Diverticulitis in the cecum/ascending occurred in 675 (72.6%) patients. The average follow-up period was 651 days. Recurrence was observed in 115 (12.4%) patients and most significantly observed in patients with sigmoid diverticulitis (HR, 2.24; 95% CIs 1.59-3.97), followed by those with descending colon diverticulitis (HR, 1.92; 95% CIs 1.17-3.25). Although most of the Asian patients had right-sided colonic diverticulitis, those with sigmoid diverticulitis had the highest risk of recurrence.Entities:
Mesh:
Year: 2022 PMID: 35296787 PMCID: PMC8927129 DOI: 10.1038/s41598-022-08708-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1The study flowchart.
Demographics of the included patients.
| Variables | Recurrence | |||
|---|---|---|---|---|
| Total | No | Yes | ||
| (n = 929) | (n = 814) | (n = 115) | ||
| < 0.01 | ||||
| 20–39 | 203 (22%) | 185 (23%) | 18 (16%) | |
| 40–64 | 438 (47%) | 390 (48%) | 48 (42%) | |
| ≧65 | 288 (31%) | 239 (29%) | 49 (43%) | |
| Male gender, n (%) | 484 (52%) | 424 (52%) | 60 (52%) | 0.75 |
| Body mass index, kg/m2* | 24.3 ± 3.8 | 24.2 ± 4.8 | 24.6 ± 3.6 | 0.71 |
| Diabetes mellitus | 102 (11%) | 78 (10%) | 24 (21%) | < 0.01 |
| Hypertension | 272 (29%) | 223 (27%) | 49 (43%) | < 0.01 |
| CAD or CVA† | 76 (8%) | 57 (7%) | 19 (17%) | < 0.01 |
| Liver cirrhosis | 15 (2%) | 14 (2%) | 1 (0.9%) | 0.56 |
| Abdominal pain | 719 (77.%) | 644 (79%) | 75 (65%) | 0.65 |
| Abdominal fullness | 23 (3%) | 18 (2%) | 5 (4%) | 0.31 |
| Nausea/vomiting | 116 (13%) | 101 (12%) | 15 (13%) | 0.59 |
| Anorexia | 70 (8%) | 68 (8%) | 2 (2%) | 0.18 |
| Dysuria | 29 (3%) | 25 (3%) | 4 (3%) | 0.08 |
| Urinary frequency | 19 (2%) | 15 (2%) | 4 (3%) | 0.50 |
| Constipation | 28 (3%) | 26 (3%) | 2 (2%) | 0.68 |
| Diarrhea | 106 (11%) | 91 (11%) | 15 (13%) | 0.78 |
| Fever | 186 (20%) | 166 (20%) | 20 (17%) | 0.12 |
| White blood cells, × 103/uL | 12.6 ± 7.4 | 12.9 ± 7.2 | 11.9 ± 3.2 | 0.08 |
| Band, % | 0.3 ± 3.7 | 0.2 ± 2.9 | 0.4 ± 2.2 | 0.27 |
| CRP†, mg/dL | 6.9 ± 6.8 | 7.9 ± 5.9 | 4.9 ± 5.7 | 0.11 |
| Creatinine, mg/dL | 1.0 ± 1.2 | 1.1 ± 1.2 | 0.9 ± 0.5 | 0.28 |
| Amylase, U/L | 43.9 ± 19.8 | 46.2 ± 12.4 | 34.2 ± 12.4 | 0.10 |
| Complicated diverticulitis, n (%) | 130 (14%) | 112 (14%) | 18 (16%) | 0.17 |
| < 0.01 | ||||
| Cecum/ascending colon | 675 (73%) | 628 (77%) | 47 (41%) | |
| Transverse colon | 29 (3%) | 27 (3%) | 2 (2%) | |
| Descending colon | 88 (10%) | 67 (8%) | 21 (18%) | |
| Sigmoid colon | 137 (15%) | 92 (11%) | 45 (39%) | |
| 10.2 ± 8.9 | 7.0 ± 8.8 | 12.9 ± 11.4 | 0.01 | |
| 7.1 ± 8.2 | 6.2 ± 7.5 | 11.2 ± 13.2 | < 0.01 | |
| 651.7 ± 617.0 | 653.1 ± 607.5 | 648.2 ± 552.6 | 0.75 | |
*Presented with mean ± standard deviation.
†CAD, coronary artery disease; CVA, cerebrovascular accident; CRP, C-reactive protein.
‡Comparisons between the recurrence and the non-recurrence groups.
Risk factors for recurrence of colonic diverticulitis.
| Variables | Cumulative | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|
| Hazard ratio | Hazard ratio | ||||
| Age, years* | |||||
| 20–39 | 21% | Reference | - | Reference | - |
| 40–64 | 28% | 1.76 (1.09–2.08) | 0.02 | 1.42 (1.18–1.68) | 0.02 |
| ≧65 | 31% | 2.85 (1.71–3.17) | < 0.01 | 2.27 (1.98–2.59) | < 0.01 |
| Diabetes mellitus | 29% | 1.87 (1.23–2.45) | < 0.01 | 1.78 (0.99–2.96) | 0.06 |
| Hypertension | 11% | 1.28 (1.03–2.75) | 0.03 | 0.85 (0.53–1.39) | 0.41 |
| CAD or CVA† | 8% | 2.09 (1.21–3.43) | < 0.01 | 1.65 (0.88–3.01) | 0.11 |
| Antibiotics duration | - | 0.82 (0.76–0.99) | 0.01 | 0.98 (0.96–1.03) | 0.35 |
| Hospitalization | - | 1.21 (1.03–1.69) | 0.02 | 1.04 (0.98–1.07) | 0.06 |
| Location* | |||||
| Cecum/Ascending | 8% | Reference | - | Reference | - |
| Transverse | 12% | 0.87 (0.08–4.23) | 0.79 | 0.72 (0.07–4.88) | 0.81 |
| Descending | 46% | 2.32 (1.21–3.61) | < 0.01 | 1.92 (1.17–3.25) | 0.01 |
| Sigmoid | 68% | 2.96 (1.48–4.27) | < 0.01 | 2.24 (1.59–3.97) | < 0.01 |
*Remained significant after adjusting other confounders.
†CAD, coronary artery disease; CVA, cerebrovascular accident.
Figure 2The Kaplan–Meier plot for recurrence free probability stratified by age groups during follow-up.
Figure 3The Kaplan–Meier plot for recurrence free probability stratified by location of diverticulitis during follow-up.
The recurrence rates for patients with different locations and age categories.
| 6-month | 12-month | 24-month | |
|---|---|---|---|
| Cecum/ascending colon | 4% | 2% | 3% |
| Transverse colon | 0 | 8% | 5% |
| Descending colon | 18% | 14% | 13% |
| Sigmoid colon | 20% | 20% | 21% |
| 20–39 | 3% | 5% | 8% |
| 40–64 | 5% | 7% | 11% |
| ≧65 | 3% | 4% | 13% |